Report : South and Central America Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country
Hospital Segment Held Largest Share of End-User in South & Central America Kidney Disease Market in 2019
According to a new market research study of ‘South & Central America Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Analysis by product, and end-user’ the South & Central America kidney disease market is expected to reach US$ 9,060.9 million in 2027 from US$ 5,758.9 in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020-2027. The report provides trends prevailing in the South & Central America kidney disease market and the factors driving market along with those that act as hindrances.
Based on the end-user, the South & Central America the kidney disease market, is segmented into hospital, diagnostic laboratories, and others. The hospital segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. Hospitals are the primary healthcare centers where the kidney diseases are extensively treated. These facility centers provide advantages presence of integrated healthcare facilities, the availability of technologically advanced infrastructures, and the ability to perform complex procedures. In addition, the availability of favorable reimbursement policies influences the increasing number of kidney disease treatment procedures. Moreover, the faster development of healthcare infrastructure facilities and a surge in healthcare spending in developing regions is expected to drive the hospitals segment’s growth over the forecast period.
The growth of this market is estimated to grow owing to key driving factors such as higher prevalence of kidney diseases in South & Central America and rising incidence rates of hypertension. However, the market is expected experiencing slow growth during the forecast period owing to an inadequate workforce to fight the burden of kidney diseases.
Abbott, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd are among the leading companies operating in the South & Central America kidney disease market.
South & Central America Kidney Disease Market, By Country, 2019(% share)
The report segments South & Central America Kidney Disease Market as Follows:
- Blood Tests
- Urine Tests
- Imaging Tests
- Drug Class
- ACE Inhibitors
- Angiotensin-II Receptor Blockers
- Diagnostic Laboratories
- South & Central America